Jeroan Allison to HIV Infections
This is a "connection" page, showing publications Jeroan Allison has written about HIV Infections.
Connection Strength
1.285
-
Mugavero MJ, Lin HY, Willig JH, Westfall AO, Ulett KB, Routman JS, Abroms S, Raper JL, Saag MS, Allison JJ. Missed visits and mortality among patients establishing initial outpatient HIV treatment. Clin Infect Dis. 2009 Jan 15; 48(2):248-56.
Score: 0.195
-
Wang B, Deveaux L, Guo Y, Schieber E, Adderley R, Lemon S, Allison J, Li X, Forbes N, Naar S. Effects of Teacher Training and Continued Support on the Delivery of an Evidence-Based HIV Prevention Program: Findings From a National Implementation Study in the Bahamas. Health Educ Behav. 2023 12; 50(6):770-782.
Score: 0.135
-
Wang B, Liu F, Deveaux L, Ash A, Gerber B, Allison J, Herbert C, Poitier M, MacDonell K, Li X, Stanton B. Predicting Adolescent Intervention Non-responsiveness for Precision HIV Prevention Using Machine Learning. AIDS Behav. 2023 May; 27(5):1392-1402.
Score: 0.127
-
Seal PS, Jackson DA, Chamot E, Willig JH, Nevin CR, Allison JJ, Raper JL, Kempf MC, Schumacher JE, Saag MS, Mugavero MJ. Temporal trends in presentation for outpatient HIV medical care 2000-2010: implications for short-term mortality. J Gen Intern Med. 2011 Jul; 26(7):745-50.
Score: 0.057
-
Nevin CR, Ye J, Aban I, Mugavero MJ, Jackson D, Lin HY, Allison J, Raper JL, Saag MS, Willig JH. The role of toxicity-related regimen changes in the development of antiretroviral resistance. AIDS Res Hum Retroviruses. 2011 Sep; 27(9):957-63.
Score: 0.057
-
Godwin NC, Willig JH, Nevin CR, Lin HY, Allison J, Gaddis K, Peterson J, Saag MS, Mugavero MJ, Raper JL. Underutilization of the AIDS Drug Assistance Program: associated factors and policy implications. Health Serv Res. 2011 Jun; 46(3):982-95.
Score: 0.056
-
Raper JL, Willig JH, Lin HY, Allison JJ, Broner MB, Mugavero MJ, Saag MS. Uncompensated medical provider costs associated with prior authorization for prescription medications in an HIV clinic. Clin Infect Dis. 2010 Sep 15; 51(6):718-24.
Score: 0.055
-
Routman JS, Willig JH, Westfall AO, Abroms SR, Varshney M, Adusumilli S, Allison JJ, Savage KG, Saag MS, Mugavero MJ. Comparative efficacy versus effectiveness of initial antiretroviral therapy in clinical trials versus routine care. Clin Infect Dis. 2010 Feb 15; 50(4):574-84.
Score: 0.053
-
McKinnell JA, Willig JH, Westfall AO, Nevin C, Allison JJ, Raper JL, Mugavero MJ, Saag MS. Antiretroviral prescribing patterns in treatment-na?ve patients in the United States. AIDS Patient Care STDS. 2010 Feb; 24(2):79-85.
Score: 0.052
-
Willig JH, Echevarria J, Westfall AO, Iglesias D, Henostroza G, Seas C, Mugavero MJ, Allison J, Paz J, Hernandez F, Tomatis C, Saag MS, Gotuzzo E. Durability of initial antiretroviral therapy in a resource-constrained setting and the potential need for zidovudine weight-based dosing. J Acquir Immune Defic Syndr. 2010 Feb; 53(2):215-21.
Score: 0.052
-
Ulett KB, Willig JH, Lin HY, Routman JS, Abroms S, Allison J, Chatham A, Raper JL, Saag MS, Mugavero MJ. The therapeutic implications of timely linkage and early retention in HIV care. AIDS Patient Care STDS. 2009 Jan; 23(1):41-9.
Score: 0.049
-
Mugavero MJ, Lin HY, Allison JJ, Giordano TP, Willig JH, Raper JL, Wray NP, Cole SR, Schumacher JE, Davies S, Saag MS. Racial disparities in HIV virologic failure: do missed visits matter? J Acquir Immune Defic Syndr. 2009 Jan 01; 50(1):100-8.
Score: 0.049
-
Robison LS, Westfall AO, Mugavero MJ, Kempf MC, Cole SR, Allison JJ, Willig JH, Raper JL, Wilcox CM, Saag MS. Short-term discontinuation of HAART regimens more common in vulnerable patient populations. AIDS Res Hum Retroviruses. 2008 Nov; 24(11):1347-55.
Score: 0.048
-
Willig JH, Abroms S, Westfall AO, Routman J, Adusumilli S, Varshney M, Allison J, Chatham A, Raper JL, Kaslow RA, Saag MS, Mugavero MJ. Increased regimen durability in the era of once-daily fixed-dose combination antiretroviral therapy. AIDS. 2008 Oct 01; 22(15):1951-60.
Score: 0.048
-
Willig JH, Jackson DA, Westfall AO, Allison J, Chang PW, Raper J, Saag MS, Mugavero MJ. Clinical inertia in the management of low-density lipoprotein abnormalities in an HIV clinic. Clin Infect Dis. 2008 Apr 15; 46(8):1315-8.
Score: 0.046
-
Willig JH, Westfall AO, Allison J, Van Wagoner N, Chang PW, Raper J, Saag MS, Mugavero MJ. Nucleoside reverse-transcriptase inhibitor dosing errors in an outpatient HIV clinic in the electronic medical record era. Clin Infect Dis. 2007 Sep 01; 45(5):658-61.
Score: 0.044
-
Mugavero MJ, Lin HY, Allison JJ, Willig JH, Chang PW, Marler M, Raper JL, Schumacher JE, Pisu M, Saag MS. Failure to establish HIV care: characterizing the "no show" phenomenon. Clin Infect Dis. 2007 Jul 01; 45(1):127-30.
Score: 0.044
-
Chen RY, Westfall AO, Hardin JM, Miller-Hardwick C, Stringer JS, Raper JL, Vermund SH, Gotuzzo E, Allison J, Saag MS. Complete blood cell count as a surrogate CD4 cell marker for HIV monitoring in resource-limited settings. J Acquir Immune Defic Syndr. 2007 Apr 15; 44(5):525-30.
Score: 0.043
-
Chen RY, Accortt NA, Westfall AO, Mugavero MJ, Raper JL, Cloud GA, Stone BK, Carter J, Call S, Pisu M, Allison J, Saag MS. Distribution of health care expenditures for HIV-infected patients. Clin Infect Dis. 2006 Apr 01; 42(7):1003-10.
Score: 0.040
-
Bedimo R, Chen RY, Accortt NA, Raper JL, Linn C, Allison JJ, Dubay J, Saag MS, Hoesley CJ. Trends in AIDS-defining and non-AIDS-defining malignancies among HIV-infected patients: 1989-2002. Clin Infect Dis. 2004 Nov 01; 39(9):1380-4.
Score: 0.036